The Lancet Respiratory Medicine in conversation with
Editors at The Lancet Respiratory Medicine, in conversation with the journal’s authors, explore their latest research and its impact on people’s health, healthcare, and health policy.
A monthly audio companion to the journal, this podcast covers a broad range of topics, from long COIVD outcomes to tobacco control, the management of uncontrolled asthma to intensive care medicine, and more.
Episodes
155 episodes
Sergio Harari sul trattamento della linfangioleiomiomatosi (LAM) (in Italian)
Il Professor Sergio Harari commenta i risultati di un trial clinico di fase 2 volto a valutare l’attivita’ e la sicurezza del farmaco nintedanib come trattamento in pazienti affetti da linfangioleiomiomatosi (LAM).
•
10:40
Sergio Harari on the treatment of lymphangioleiomyomatosis (LAM)
Professor Sergio Harari joins us to discuss the results of a phase 2 clinical trial evaluating activity and safety of nintedanib in people with lymphangioleiomyomatosis (LAM).
•
10:26
Robert Kullberg on empirical antibiotics for Sepsis
Dr Robert Kullberg joins us to discuss his Viewpoint on empiric antibiotic therapy for sepsis and the importance of reducing unnecessary use of anti-anaerobic antibiotics.Read the full article:
•
12:06
Heather Zar on early-life RSV disease and long-term respiratory health
Professor Heather Zar joins The Lancet Respiratory Medicine to discuss early-life RSV disease and long-term respiratory health. This topic will be covered in one of four Series papers in a cross-journal Series with The Lancet....
•
19:07
Margaux Mesle on lives saved by COVID-19 vaccination
Dr Margaux Mesle discusses estimates of lives directly saved by COVID-19 vaccination programs in the WHO European Region in the period from 2020 to 2023 and public health implications.Read the full article:
•
10:21
James Hull on protecting the respiratory health of athletes
Professor James Hull joins us to discuss his recent Spotlight on protecting the respiratory health of athletes ahead of the Summer Olympics and Paralympics.Read the full article:
•
11:04
Eric Lim on treatments for pleural mesothelioma
Professor Eric Lim discusses the outcomes after extended pleurectomy decortication plus chemotherapy versus chemotherapy alone for pleural mesothelioma.
•
6:17
Anne Chang on the burden of chronic respiratory diseases in Indigenous people
Dr Anne Chang discusses the burden of chronic respiratory diseases in Indigenous people.Read the full article:
•
9:49
Daniel Steinfort and Shankar Siva on radiotherapy field planning in patients with NSCLC
Professor Daniel Steinfort and Professor Shankar Siva discuss the effect of systematic endoscopic mediastinal staging on radiotherapy field planning in patients with locally advanced non-small-cell lung cancer.
•
10:23
Daniel Prieto-Alhambra, Annika Jödicke, and Martí Català on vaccination to prevent Long COVID
Prof Daniel Prieto-Alhambra, Dr Annika Jödicke, and Dr Martí Català discuss the effectiveness of COVID-19 vaccines to prevent Long COVID, estimated to affect up to 20% of those infected with SARS-CoV-2.Read the full article:
•
8:16
Sarah Gorst and Tim Nicholson on long COVID outcomes
Dr Tim Nicholson and Dr Sarah Gorst discuss the development of an international Delphi consensus study on a core outcome measurement set for long COVID and how it will be used to inform future research and clinical care.
•
15:32
Betty Raman on multiorgan MRI abnormalities after hospitalisation with COVID-19
Dr Betty Raman discusses multiorgan MRI findings in patients after hospitalisation with COVID-19.Read the full article:
•
12:02
Keith Chappell on a bivalent recombinant vaccine for COVID-19
Dr Keith Chappell discusses the bivalent recombinant vaccine for COVID-19 following the study by Dayan and colleagues, with focus on vaccine access, variants and boosters, tolerability and side effects, as well as hopes for future trials.
•
8:13
James Chalmers on bronchiectasis across Europe
Prof. James Chalmers discusses the characteristics of patients with bronchiectasis across Europe, the differences between countries, and possible differences in clinical outcomes, based on data from the EMBARC registry.Read the full art...
•
11:57
Richard Costello on management of uncontrolled asthma
Prof Richard Costello discusses the use of digital measurements of medication adherence and lung function to guide management of uncontrolled asthma.
•
11:38
Keiju Aokage on segmentectomy for ground-glass-dominant lung cancer
Dr Keiju Aokage discusses segmentectomy for ground-glass-dominant lung cancer with a tumour diameter of 3 cm or less.Read the full article:
•
5:51
Carol Hodgson on post-discharge outcomes for ECMO patients
Carol Hodgson discusses recent advances in our understanding of in-hospital and post-discharge outcomes in critically ill patients who receive ECMO.Read the full article:
•
19:16
Emma Grainger on 10 years of The Lancet Respiratory Medicine
Emma Grainger, Editor-in-Chief of The Lancet Respiratory Medicine, discusses the January issue and plans to celebrate the 10-year anniversary of the journal. Read the Editorial from the 10th anniversary issue:
•
13:06
Vivienne Kahlmann and Catharina Moor on the TIRED study
Vivienne Kahlmann and Catharina Moor discuss a study looking at online mindfulness-based cognitive behaviour treatment to address fatigue associated with sarcoidosis. Read the full article:
•
9:00
Yves Lacasse on long-term oxygen therapy for COPD
Yves Lacasse joins The Lancet Respiratory Medicine to discuss a meta-analysis on the effectiveness of home oxygen use for patients with COPD.Read the full article:
•
17:15
Rachael Evans on living with long COVID
Rachael Evans discusses the needs of people with long COVID and the latest findings from the PHOSP-COVID study.Read the full article:Physi...
•
13:28
Daniel Munblit and Dale Needham on core outcomes post-COVID-19
Daniel Munblit and Dale Needham discuss the importance of developing a core outcome set for post-COVID-19 condition.Read the full Position Paper:
•
16:37
Daiana Stolz on antibiotic stewardship in pneumonia
Daiana Stolz discusses antibiotic stewardship in patients hospitalised with pneumonia and at risk of Gram-negative bacterial infection. Read the full article:
•
10:16